All In MedTech

Device Trial Radar · NCT04214535

Anterior Cervical Disectomy And Fusion Using The Tritanium® C Anterior Cervical Cage For One Or Two-Levels

Anterior Cervical Disectomy And Fusion Using The Tritanium® C Anterior Cervical Cage For One Or Two-Levels: A Clinical And Radiographic Analysis Pilot Study

Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

May 5, 2021

Primary completion

Mar 30, 2027

Study completion Mar 30, 2028

Sponsor

Lead sponsor
Corewell Health EastAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
VB Spine, LLC
First posted
Jan 2, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, single arm clinical study to evaluate fusion status and patient reported outcomes utilizing the Stryker Tritanium® C Anterior Cervical interbody device at one or two contiguous levels. Subjects that are recommended for surgical treatment of either a 1- or 2-level ACDF (Anterior Cervical Discectomy and Fusion) between the levels of Cervical Spine 2 to Thoracic 1 (C2-T1) and diagnosed with degenerative disc disease will be screened for the study.

Conditions

  • Cervical Disc Herniation
  • Cervical Disc Degeneration
  • Degenerative Disc Disease

Interventions

  • Tritanium C Anterior Cervical CageDevice

    50 subjects undergoing anterior cervical discectomy and fusion surgery using the Tritanium C Anterior Cage for one or two-levels

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of successful cervical fusion measured radiographicallyTime frame: 12 months postoperative

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Corewell Health William Beaumont University Hospital

    Royal Oak, Michigan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.